KRAS and non-small cell lung carcinoma: The results were 1.13 ± 1.08 in the non-cancerous cells, 1.22 ± 1.01 in the NSCLC cells with an EGFR mutation, 0.69 ± 0.17 in the NSCLC cells with a BRAF mutation, 1.09 ± 1.09 in the NSCLC cells with wild-type EGFR/BRAF/KRAS, 0.72 ± 0.27 in the NSCLC cells with a KRAS mutation, and 19.42 ± 44.16 in the SCLC cells.